Gastroenterology Research and Practice / 2017 / Article / Tab 2

Research Article

Factors Related to Significant Improvement of Estimated Glomerular Filtration Rates in Chronic Hepatitis B Patients Receiving Telbivudine Therapy

Table 2

Comparisons of the changes in the mean eGFR (CKD-EPI) of different subgroups of chronic hepatitis B patients treated with telbivudine therapy over time.

Wald chi-squaredf value

HBeAgPositive versus negative1.0410.308
Interaction term14.3270.046
CirrhosisYes versus no0.1610.691
Interaction term1.3470.987
Complete response at 6th monthYes versus no0.2610.607
Interaction term7.8170.350
DecompensationYes versus no2.0110.156
Interaction term5.3770.614
HBV DNA ≥ 7 log IU/mLYes versus no0.0010.966
Interaction term6.4070.494
Age ≥ 50 yearsYes versus no11.7710.001
Interaction term21.1570.004
GenotypeB versus C5.3910.020
Interaction term11.5770.116

Analysis by generalized estimating equations. df: degree of freedom.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.